ADMA Biologics Inc
Biotechnology
Healthcare
ADMA
245 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
17.50
52 week high
22.62
high
19.74
52 week low
10.44
low
17.30
growth
103.04 %
previous Close
17.86
P/E ratio
market cap
4.19 B
div yield
0
net incoming
35.91 M
12.00 %
net profit margin
29.96 %
0.05 %
operating incoming
39.64 M
1.11 %
net change in cash
-1.54 M
-103.58 %
cash on hand
86.71 M
-1.74 %
cost of revenue
60.18 M
20.65 %
top